Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof
Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692)
11/2000
11/28/2000US6153590 Biologically active peptides and compositions, their use
11/28/2000US6153588 Stable non-hygroscopic crystalline form of N-[N-[N-4-(piperidin-4-yl)butanoyl)-N-ethylglycyl] aspartyl]-L-β-cyclohexyl alanine amide
11/28/2000US6153585 Arylsulfonanilide derivatives
11/28/2000US6153396 Drug screening by adding compound to mixture of chaperone and pilus subunit and determining the change in binding; bactericides for urinary tract infections
11/28/2000US6153375 Making combinatorial libraries by using specific solid support and then repeatedly adding reagent, recording identify of zones, and subdividing batches
11/28/2000US6153171 Methods for identifying compounds effective for treating neurodegenerative disorders and for monitoring the therapeutic intervention therefor
11/28/2000CA2137348C Synthetic peptide lung surfactants having covalently bonded antioxidants
11/23/2000WO2000069911A1 Long lasting insulinotropic peptides
11/23/2000WO2000069889A1 Phosphonic and carboxylic acid derivatives as inhibitors of protein tyrosine phosphatase-1b (ptp-1b)
11/23/2000WO2000069472A2 Enzyme-activated anti-tumor prodrug compounds
11/23/2000WO2000031124A3 Peptides that modulate the interaction of b class ephrins and pdz domains
11/23/2000WO2000017369A3 Alzheimer's disease secretase
11/23/2000CA2623458A1 Protection of endogenous therapeutic peptides from peptidase activity through conjugation to blood components
11/23/2000CA2501421A1 Long lasting exendin-4
11/23/2000CA2372116A1 Phosphonic and carboxylic acid derivatives as inhibitors of protein tyrosine phosphatase-1b (ptp-1b)
11/23/2000CA2370245A1 Enzyme-activated anti-tumor prodrug compounds
11/22/2000EP1054017A1 Salts of thrombin inhibitors
11/22/2000EP1053246A1 Beta-sheet mimetics and methods relating to the use thereof
11/22/2000EP1052994A2 Use of dipeptidylpetidase inhibitors to regulate glucose metabolism
11/22/2000EP0669936B1 Mercaptoacetylamide bicyclic lactam derivatives useful as inhibitors of enkephalinase and ace
11/22/2000EP0663823B1 Inhibition of angiogenesis by synthetic matrix metalloprotease inhibitors
11/22/2000CN1274362A Method for crystallizing maleic acid salt of n-(1(s)-ethoxycarbonyl-3-phenylpropyl)-L-alanyl-L-proline
11/22/2000CN1274288A Peptide-containing & alpha; -ketoamide cysteine and serine protease inhibitors
11/22/2000CN1274285A Alpha-ketoamide multicatalytic protease inhibitors
11/21/2000US6150556 Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
11/21/2000US6150530 Amidation of amine with acid
11/21/2000US6150378 Peptidyl-containing α-ketoamide cysteine and serine protease inhibitors
11/21/2000US6150344 Useful for treatment of diseases such as malaria and alzheimer's disease; compounds are attached to a solid support
11/21/2000US6150335 Treatment for pain
11/21/2000US6150334 Serine protease inhibitors-tripeptoid analogs
11/21/2000US6150081 Nucleated with peptizer
11/21/2000CA2203694C Cancer inhibitory peptides
11/16/2000WO2000068263A2 Stereoselective antifibrillogenic peptides and peptidomimetics thereof
11/16/2000WO2000068255A2 Tetrapeptide revealing geroprotective effect, pharmacological substance on its basis, and the method of its application
11/16/2000WO2000068254A1 Spray drying of thrombin inhibitors
11/16/2000WO2000067801A2 Prodrugs of chemotherapeutic agents with oxaalkanoic acids
11/16/2000WO2000038665A3 Use of an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
11/16/2000WO2000035887A3 Vitronectin receptor antagonist pharmaceuticals
11/16/2000WO1999051186A3 Methods and compositions for the diagnosis and treatment of neuropsychiatric disorders
11/16/2000DE19921346A1 Sprühtrocknung von Thrombininhibitoren Spray drying of thrombin inhibitors
11/16/2000CA2388092A1 Stereoselective antifibrillogenic peptides and peptidomimetics thereof
11/16/2000CA2373068A1 Spray drying of thrombin inhibitors
11/16/2000CA2368831A1 Permeable, water soluble, non-irritating prodrugs of chemotherapeutic agents with oxaalkanoic acids
11/15/2000EP1051431A1 Thrombin inhibitors
11/15/2000EP0817795B1 Novel 4-substituted-3-peptidyl-azetidin-2-one derivatives useful as cysteine proteinase inhibitor
11/15/2000CN1058487C 1,5-benzodiazepine derivatives having CCK antagoistic or agonistic activity
11/14/2000US6147212 Proline-naphthylalanine dipeptide amidated with an acyl derivative on the n-terminus and a 4-phenyl-1-piperazinyl derivative on the carboxyl terminus; neurokinin (tachykinin) antagonist
11/14/2000US6147188 Irreversible cathepsin or calpain inhibitors
11/14/2000US6147187 Major histocompatibility complex proteins; for diagnosis and treatment of tumors; antitumor agents
11/14/2000US6147073 Substituted tetralymethylen-Oxindoles analogues as tyrosine kinase inhibitors
11/14/2000US6146680 Liquid low-calorie sweetener
11/09/2000WO2000066618A1 Integrin receptor antagonists
11/09/2000WO2000066587A2 Polyamines and their use in therapy
11/09/2000WO2000066528A2 Quinones for treatment of diseases
11/09/2000WO2000066175A2 Conjugates as therapies for cancer and prostate diseases
11/09/2000WO2000038718A3 Use of matrix metalloproteinase inhibitor together with an antineoplastic agents, optionally also together with radiation, in the treatment of neoplasia
11/09/2000WO2000035488A3 Vitronectin receptor antagonist pharmaceuticals
11/09/2000CA2372611A1 Quinones for treatment of diseases
11/09/2000CA2371604A1 Integrin receptor antagonists
11/09/2000CA2368801A1 Conjugates as therapies for cancer and prostate diseases
11/08/2000EP1050540A2 Inhibitors of dipeptidyl-aminopeptidase type IV
11/08/2000EP1050534A1 2,3-methano-amino acid derivatives, process for their preparation and pharmaceutical compositions containing them
11/08/2000EP1049793A2 Transfecting compositions sensitive to reducing conditions, pharmaceutical compositions containing them, and their applications
11/08/2000EP1049710A1 Peptides with beta-1 integrin subunit dependent cell adhesion modulating activity
11/08/2000EP1049703A1 N-[2-(5-benzyloxycarbonyl-amino-6-oxo-2-(4-fluorophenyl)-1,6-dihydro-1-pyrimidinyl)acetoxyl]-l-aspartic acid aldehyde as an in vivo inhibitor of interleukin-1beta converting enzyme
11/08/2000EP1049673A1 Heterocyclic amidines as callicrein protease inhibitors
11/08/2000EP1049481A2 Synthetic antineoplastic agents derived from dolastatin 15 and methods of making same
11/08/2000EP0769006B1 Small molecule inhibitors of rotamase enzyme activity
11/07/2000US6143932 Selectively N-alkylated peptidomimetic combinatorial libraries and compounds therein
11/07/2000US6143886 Azepinone compounds useful in the inhibition of ACE and NEP
11/07/2000US6143788 Bis-amino acid hydroxyethlamino sulfonamide retroviral protease inhibitors
11/07/2000US6143739 Antimicrobial agents mainly active against gram positive bacteria
11/07/2000US6143734 Nitroso esters of β-oxo-amides and aryl propionic acid derivatives of non-steroidal antiinflammatory drugs
11/07/2000US6143719 Bradykinin analogs as selective thrombin inhibitors
11/07/2000US6143716 Liposomal peptide-lipid conjugates and delivery using same
11/07/2000US6143497 Synthesizing random oligomers on particles using identification tags to facilitate identification of sequence of monomers
11/02/2000WO2000064946A2 Compositions and methods for cancer treatment by selectively inhibiting vegf
11/02/2000WO2000064926A1 Melanocyte-stimulating hormone inhibitors
11/02/2000WO2000064863A1 Use of 2,4-diamino-3-hydroxycarboxylic acid derivatives as proteasome inhibitors
11/02/2000WO2000038730A3 Use of a cyclooxygenase-2 inhibitor and one or more antineoplastic agents for combination therapy in neoplasia
11/02/2000EP1048674A1 Method for separating and purifying aspartame and aspartame derivative
11/02/2000EP1048223A1 Sweetener compositions containing aspartame and aspartame derivative
11/02/2000EP1047709A1 Compounds with growth hormone releasing properties
11/02/2000EP1047708A1 Peptide chelators that predominately form a single stereoisomeric species upon coordination to a metal center
11/02/2000EP1047445A1 Modified enzymes and their use for peptide synthesis
11/02/2000EP0914331B1 Neuroactive peptides
11/01/2000CN1272114A Phenethylamine derivatives
11/01/2000CN1058021C New peptides derived from trifluorumethylketones, process for their preparation and pharmaceutical compositions which contain them
11/01/2000CN1058020C Angiotensin converting enzyme inhibitor and method for preparing same
11/01/2000CN1058019C 环状氨基酸衍生物 Cyclic amino acid derivatives
11/01/2000CN1058013C Process for preparation of novel mercaptoacetylamide derivatives
10/2000
10/31/2000US6140505 Synthesis of benzo fused heterocyclic sulfonyl chlorides
10/31/2000US6140493 Method of synthesizing diverse collections of oligomers
10/31/2000US6140357 Small molecule inhibitors of rotamase enzyme activity
10/31/2000US6139862 Pharmaceutical dipeptide compositions and methods of use thereof
10/26/2000WO2000063328A1 Perfume precursor compositions and method for expressing perfume components
10/26/2000WO2000063247A2 Osteopontin-derived chemotactic and inhibitory agents and uses therefor
10/26/2000WO2000063236A2 Adhesion modulatory peptides and methods for use
10/26/2000WO2000063234A2 Pyrrolidincarbonylamino cyclic disulfides as vcam-vla4 antagonists
10/26/2000WO2000063233A2 Peptides and the use thereof to control pests
1 ... 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 ... 307